Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
İsim Soyisim
Yagiz Uresin
Başlık
Prof
Bio
Born in Istanbul. Graduated from Istanbul College 1980, Istanbul Medical Faculty 1986, finished specialization in Pharmacology in 1990. Worked in Istanbul Medical Faculty Dept. of Cardiology 1987-88, Human Pharmacolgy Sandoz Basel 1991-1993. Became associate professor at 1997, professor at 2004, head of the department at 2006, head of the division of Clinical Pharmacology at 2014.
Performed clinical trials on phase I to IV, has documents in FDA, was the principal investigator of international multicenter hypertension study, was Erasmus coordinator of the Istanbul Medical Faculty.
Is vice Director of the IU Clinical Research Center of Excellence, and IU Drug Research Center, chairperson of the Ethics Committee of Istanbul Medical Faculty, Board Member of the Istanbul University Biotechnology and Genetical Engineering Center, Member of the State Representatives Group of Innovational Medicines Initiative of EU, was ethics consultant of the IMI SAFE-T project, is Member of the Steering Board and former Chairperson of the International Clinical Trial Center Network, Chairperson of Turkish Atherosclerosis Society, Hypertension Specialist of the European Society of Hypertension. Speaks Turkish, German & English.
Scientific interests; translational science, clinical research, biomarkers, atherosclerosis (hypertension and dislipidaemia in particular) stress and neuroscience.
Performed clinical trials on phase I to IV, has documents in FDA, was the principal investigator of international multicenter hypertension study, was Erasmus coordinator of the Istanbul Medical Faculty.
Is vice Director of the IU Clinical Research Center of Excellence, and IU Drug Research Center, chairperson of the Ethics Committee of Istanbul Medical Faculty, Board Member of the Istanbul University Biotechnology and Genetical Engineering Center, Member of the State Representatives Group of Innovational Medicines Initiative of EU, was ethics consultant of the IMI SAFE-T project, is Member of the Steering Board and former Chairperson of the International Clinical Trial Center Network, Chairperson of Turkish Atherosclerosis Society, Hypertension Specialist of the European Society of Hypertension. Speaks Turkish, German & English.
Scientific interests; translational science, clinical research, biomarkers, atherosclerosis (hypertension and dislipidaemia in particular) stress and neuroscience.
